Nutra Pharma’s Nyloxin claims to relieve cancer pain and potentially help treat opioid addiction, among others, mark its products as unapproved new drugs, FDA asserts in a warning letter that reflects its homeopathic enforcement approach proposed in late 2017.  “Health fraud scams like these are inexcusable,” says FDA Commissioner Scott Gottlieb.

FDA advised Hanna’s Herb Shop to discontinue drug claims for more than a dozen Kroeger herbal supplements, including “decrease dementia” or tackle “hypertension.” Separately, agency sets a date for its “Responsible Innovation” meeting for regulating the vitamin, mineral and supplement industry.

Aspirin should be used very selectively in the primary prevention of artherosclerotic cardiovascular disease, according to new guidelines from the American College of Cardiology and American Heart Association. While certain higher-risk adults may benefit from regular, preventative aspirin use, those over the age of 70, and any at increased risk of bleeding, should explore lifestyle changes, the groups say.

P&G’s introduction of Waterless hair care in South Africa, where water is a precious commodity, marks the first new retail hair-care brand for the firm in four years. Meanwhile, liquid-free DS3 shampoo, body wash and other personal-care swatches, available now for pre-order, support P&G’s sustainability goals while representing attractive cost efficiencies.

California Prop 65 amendment has retailers asking manufacturers for unrealistic guarantees that no products contain any Prop 65 chemicals, says Clif Bar & Co. Chief Counsel Amy Norris. Manufacturers should develop standard response to retailers' myriad requests and develop a plan to address any issues that could arise.

Supplementation with omega-3s, folic acid, vitamin D3, calcium and selenium did not reduce MDD onset in overweight subjects with history of depression, according to first RCT on effectiveness of two nutritional strategies and their combination in preventing depression among high-risk subjects.